Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysis
Background and Objectives While brentuximab vedotin (BV) and radiotherapy (RTx) are established treatment options for CD30-positive cutaneous T-cell lymphoma (CTCL), data on their simultaneous or sequential use regarding efficacy and tolerability remain scarce. In this retrospective analysis, we eva...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2025
|
| In: |
Journal der Deutschen Dermatologischen Gesellschaft
Year: 2025, Pages: 1-8 |
| ISSN: | 1610-0387 |
| DOI: | 10.1111/ddg.15897 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1111/ddg.15897 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/ddg.15897 
|
| Verfasserangaben: | Patrick Schummer, Caroline Glatzel, Philipp Schrüfer, Ingulf Lawrenz, Gabor Dobos, Ulrike Wehkamp, Svea Hüning, René Stranzenbach, Jan P. Nicolay, Matthias Goebeler, Marion Wobser |
MARC
| LEADER | 00000naa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1961086433 | ||
| 003 | DE-627 | ||
| 005 | 20260213153411.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 260213s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/ddg.15897 |2 doi | |
| 035 | |a (DE-627)1961086433 | ||
| 035 | |a (DE-599)KXP1961086433 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schummer, Patrick |e VerfasserIn |0 (DE-588)1197556389 |0 (DE-627)1679225391 |4 aut | |
| 245 | 1 | 0 | |a Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysis |c Patrick Schummer, Caroline Glatzel, Philipp Schrüfer, Ingulf Lawrenz, Gabor Dobos, Ulrike Wehkamp, Svea Hüning, René Stranzenbach, Jan P. Nicolay, Matthias Goebeler, Marion Wobser |
| 264 | 1 | |c 2025 | |
| 300 | |b Diagramme | ||
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 13.02.2026 | ||
| 520 | |a Background and Objectives While brentuximab vedotin (BV) and radiotherapy (RTx) are established treatment options for CD30-positive cutaneous T-cell lymphoma (CTCL), data on their simultaneous or sequential use regarding efficacy and tolerability remain scarce. In this retrospective analysis, we evaluated the combination of BV and RTx in patients with CD30-positive CTCL. Patients and Methods We included 14 CD30-positive CTCL patients from six German cancer centers receiving BV; RTx was initiated within a timeframe of 3 months prior/after BV treatment. RTx was mainly applied as a low-dose scheme. Results Adverse events of any grade occurred in 71% of patients, most commonly peripheral neuropathy, neutropenia, and radiodermatitis. Thirteen patients achieved a complete or partial remission as best overall response, however, 50% of all patients showed disease progression. At a median follow-up of 14.4 months, median progression-free survival was 12.0 months, with a 1-year rate of 34.0%. Conclusions The simultaneous or sequential use of RTx during BV treatment was feasible and well tolerated. Future randomized investigations are needed to identify the benefits of this combination treatment regimen as well as adequate dosing of BV and RTx in a prospective manner. | ||
| 650 | 4 | |a Brentuximab vedotin | |
| 650 | 4 | |a cutaneous T-cell lymphoma | |
| 650 | 4 | |a radiotherapy | |
| 700 | 1 | |a Glatzel, Caroline |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schrüfer, Philipp |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lawrenz, Ingulf |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dobos, Gabor |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wehkamp, Ulrike |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hüning, Svea |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stranzenbach, René |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nicolay, Jan Peter |d 1981- |e VerfasserIn |0 (DE-588)138614474 |0 (DE-627)604867352 |0 (DE-576)308046188 |4 aut | |
| 700 | 1 | |a Goebeler, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wobser, Marion |d 1979- |e VerfasserIn |0 (DE-588)132196077 |0 (DE-627)519228081 |0 (DE-576)298999161 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a Deutsche Dermatologische Gesellschaft |t Journal der Deutschen Dermatologischen Gesellschaft |d Berlin : Wiley-Blackwell, 2003 |g (2025), Seite 1-8 |h Online-Ressource |w (DE-627)362755833 |w (DE-600)2099463-1 |w (DE-576)103373837 |x 1610-0387 |7 nnas |
| 773 | 1 | 8 | |g year:2025 |g pages:1-8 |g extent:8 |a Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysis |
| 856 | 4 | 0 | |u https://doi.org/10.1111/ddg.15897 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/ddg.15897 |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20260213 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 138614474 |a Nicolay, Jan Peter |m 138614474:Nicolay, Jan Peter |d 60000 |d 61900 |e 60000PN138614474 |e 61900PN138614474 |k 0/60000/ |k 1/60000/61900/ |p 9 | ||
| 999 | |a KXP-PPN1961086433 |e 4916223128 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 13.02.2026"],"id":{"eki":["1961086433"],"doi":["10.1111/ddg.15897"]},"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"given":"Patrick","family":"Schummer","role":"aut","display":"Schummer, Patrick"},{"family":"Glatzel","given":"Caroline","display":"Glatzel, Caroline","role":"aut"},{"given":"Philipp","family":"Schrüfer","display":"Schrüfer, Philipp","role":"aut"},{"display":"Lawrenz, Ingulf","role":"aut","given":"Ingulf","family":"Lawrenz"},{"given":"Gabor","family":"Dobos","role":"aut","display":"Dobos, Gabor"},{"role":"aut","display":"Wehkamp, Ulrike","family":"Wehkamp","given":"Ulrike"},{"role":"aut","display":"Hüning, Svea","family":"Hüning","given":"Svea"},{"given":"René","family":"Stranzenbach","role":"aut","display":"Stranzenbach, René"},{"family":"Nicolay","given":"Jan Peter","display":"Nicolay, Jan Peter","role":"aut"},{"given":"Matthias","family":"Goebeler","display":"Goebeler, Matthias","role":"aut"},{"role":"aut","display":"Wobser, Marion","family":"Wobser","given":"Marion"}],"recId":"1961086433","title":[{"title":"Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysis","title_sort":"Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysis"}],"physDesc":[{"extent":"8 S.","noteIll":"Diagramme"}],"origin":[{"dateIssuedDisp":"2025","dateIssuedKey":"2025"}],"name":{"displayForm":["Patrick Schummer, Caroline Glatzel, Philipp Schrüfer, Ingulf Lawrenz, Gabor Dobos, Ulrike Wehkamp, Svea Hüning, René Stranzenbach, Jan P. Nicolay, Matthias Goebeler, Marion Wobser"]},"relHost":[{"corporate":[{"role":"aut","display":"Deutsche Dermatologische Gesellschaft"}],"part":{"extent":"8","year":"2025","text":"(2025), Seite 1-8","pages":"1-8"},"note":["Gesehen am 03.03.10"],"titleAlt":[{"title":"JDDG"}],"recId":"362755833","origin":[{"dateIssuedKey":"2003","publisher":"Wiley-Blackwell ; Blackwell","dateIssuedDisp":"2003-","publisherPlace":"Berlin ; Berlin"}],"titleTranslated":[{"translated":"Journal of the German Society of Dermatology"}],"disp":"Deutsche Dermatologische GesellschaftJournal der Deutschen Dermatologischen Gesellschaft","id":{"doi":["10.1111/(ISSN)1610-0387"],"eki":["362755833"],"issn":["1610-0387"],"zdb":["2099463-1"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["ger","eng"],"title":[{"title_sort":"Journal der Deutschen Dermatologischen Gesellschaft","title":"Journal der Deutschen Dermatologischen Gesellschaft","subtitle":"JDDG = Journal of the German Society of Dermatology"}],"pubHistory":["1.2003 -"],"physDesc":[{"extent":"Online-Ressource"}]}]} | ||
| SRT | |a SCHUMMERPABRENTUXIMA2025 | ||